Navigation Links
IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions

WEBSTER, Texas, Jan. 31, 2013 /PRNewswire/ -- IDEV Technologies, Inc. today announced results from a new study by physicians from Tucson, Arizona, which were reported at last week's LINC meeting in Leipzig, Germany.  The data matched previously reported results with the Supera® Stent in other studies, but in a group of patients with more advanced peripheral disease.

One hundred forty-seven patients from Tucson were included in the analysis.  Long lesions were studied, with the mean lesion length of their superficial femoral artery (SFA) and popliteal artery disease of 18.4 cm, which was treated by an average stent length of 19.7 cm.  The study included patients with TASC II C & D disease (28 and 33% respectively).  In addition, 35% of the patients had tissue loss and were accounted for via Rutherford Becker 5 & 6 classification, and 53% of all patients had chronic total occlusions (CTO).  The overall primary patency rate, measured by duplex ultrasound, at one year follow-up was 88%.  Zero fractures were found within a subgroup analysis of 47 patients which received follow-up x-ray evaluation.

"Our experience included patients with a significant burden of disease," commented John Pacanowski , MD, Chief of Vascular Surgery, Tucson Medical Center. Based on the broad in-depth overall volume of data for Supera, combined with the results from our study, we believe Supera could become the stent of choice for long and calcified lesions and the primary device for highly diseased patients.  Dr. Pacanowski also noted the vascular mimetic stent (VMS) design of Supera may better serve these type of anatomy, which are characterized by a location and disease state that are subject to extreme mechanical stresses.

"We are pleased to see impressive results like these in this type of challenging patient cohort," confirmed Chris Owens , President and CEO of IDEV Technologies.  "It is encouraging that physicians are continuing to reproduce positive results such as those reported earlier in European studies, even when Supera is utilized across a broad range of disease states, operators, various studies and clinical sites."

About the Supera StentThe Supera stent is engineered with proprietary interwoven wire technology that mimics vascular anatomy.  It is currently indicated in the U.S. for the palliative treatment of biliary strictures produced by malignant neoplasms and in multiple other countries for the treatment of biliary strictures produced by malignant neoplasms and for peripheral vascular use following failed percutaneous transluminal angioplasty (PTA).

About IDEV Technologies, Inc.IDEV is a developer of endovascular technologies designed to protect and restore anatomical function. The company is focused on redefining the endovascular treatment paradigm by providing physicians and patients with a new standard of technologies that deliver clinical excellence. For more information, please visit

Trent Reutiman Global Vice President of Commercial OperationsIDEV Technologies, Incorporated(281) 525-2000

SOURCE IDEV Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
Breaking Medicine News(10 mins):